Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (25298)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10573-10583 [PMID: 26457017 DOI: 10.3748/wjg.v21.i37.10573] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i37/10573.htm |
| Number | Citing Articles |
| 1 |
Weizhen Huang, Jun Li, Xiaohong Guo, Yingchu Zhao, Xia Yuan. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2. Biomedicine & Pharmacotherapy 2016; 81: 431 doi: 10.1016/j.biopha.2016.04.034
|
| 2 |
Ting Wang, Wen-Xue Chen, Guo-Feng Xu, Bei Zhang, Shu-Qin Wei, Jia Hu, Kun-He Zhang. A universal strategy designed for selecting bench-to-bedside aptamers to serum and validated in hepatocellular carcinoma diagnosis. Microchemical Journal 2019; 150: 104152 doi: 10.1016/j.microc.2019.104152
|
| 3 |
Shun Tamaki, Hiromasa Imaishi. Inhibitory effects of type 2 diabetes serum components in P450 inhibition assays can potential diagnose asymptomatic diabetic mice. Drug Metabolism and Pharmacokinetics 2020; 35(6): 497 doi: 10.1016/j.dmpk.2020.07.003
|
| 4 |
Lin Xiang, La-Mei Chen, Yu-Jia Zhai, Wei-Juan Sun, Jie-Ru Yang, Yu-Chen Fan, Kai Wang. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma. Life Sciences 2021; 270: 119061 doi: 10.1016/j.lfs.2021.119061
|
| 5 |
Chenjun Huang, Xiao Xiao, Lin Tong, Zhiyuan Gao, Jun Ji, Lin Zhou, Ya Li, Lijuan Liu, Huijuan Feng, Meng Fang, Chunfang Gao. Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers. Journal of Hepatocellular Carcinoma 2024; : 411 doi: 10.2147/JHC.S447700
|
| 6 |
Guanlin Zhou, Yijun Zeng, Yingmin Luo, Sheng Guo, Longyuan Bao, Qiong Zhang. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma. European Journal of Surgical Oncology 2022; 48(1): 95 doi: 10.1016/j.ejso.2021.06.015
|
| 7 |
Laura Guerrero, Alberto Paradela, Fernando J. Corrales. Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases. Metabolites 2022; 12(9): 779 doi: 10.3390/metabo12090779
|
| 8 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 9 |
Jihan Wang, Yangyang Wang, Jing Xu, Qiying Song, Jingbo Shangguan, Mengju Xue, Hanghui Wang, Jingyi Gan, Wenjie Gao. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. Science Progress 2021; 104(3): 003685042110294 doi: 10.1177/00368504211029429
|
| 10 |
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181423
|
| 11 |
John-Alexander Preuß, Peggy Reich, Nicole Bahner, Janina Bahnemann. Aptamers in Biotechnology. Advances in Biochemical Engineering/Biotechnology 2020; 174: 43 doi: 10.1007/10_2020_125
|
| 12 |
Vaneet Jearth, Prachi S. Patil, Shaesta Mehta, Sridhar Sundaram, Vishal Seth, Mahesh Goel, Shraddha Patkar, Munita Bal, Vidya Rao. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken. Journal of Clinical and Experimental Hepatology 2022; 12(3): 841 doi: 10.1016/j.jceh.2021.11.006
|
| 13 |
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences 2021; 22(23): 13073 doi: 10.3390/ijms222313073
|
| 14 |
Xue-Min Wu, Zhi-Feng Xi, Pinhu Liao, Hong-Dong Huang, Xiao-Ying Huang, Chao Wang, Yun Ma, Qiang Xia, Jin-Guang Yao, Xi-Dai Long. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1. Oncotarget 2017; 8(46): 81235 doi: 10.18632/oncotarget.16027
|
| 15 |
Steven Alexander Mann, Romil Saxena. Predictive Biomarkers in Oncology. 2019; : 437 doi: 10.1007/978-3-319-95228-4_40
|
| 16 |
Diana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, Pruthviraj Uchila, Mette Juul Nielsen, Alexander L Reese-Petersen, David van der Poorten, Mohammed Eslam, Detlef Schuppan, Morten Asser Karsdal, Jacob George. Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma. Hepatic Oncology 2021; 8(2) doi: 10.2217/hep-2020-0030
|
| 17 |
Xiao-Ying Huang, Chun-Ying Luo, Xue-Ming Wu, Jin-Guang Yao, Chao Wang, Bing-Chen Huang, Jun Lu, Xing-Zhizi Wang, Tian-Qi Zhang, Qiang Xia, Xi-Dai Long. Aflatoxin-Control, Analysis, Detection and Health Risks. 2017; doi: 10.5772/intechopen.68419
|
| 18 |
Shouzhang Yang, Huajie Cai, Bingren Hu, Jinfu Tu. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Bioscience Reports 2019; 39(7) doi: 10.1042/BSR20190615
|
| 19 |
Jing Zhen, Jingying Pan, Xuanrui Zhou, Zichuan Yu, Yike Jiang, Yiyang Gong, Yongqi Ding, Yue Liu, Liangyun Guo. FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma. Aging 2023; doi: 10.18632/aging.204619
|
| 20 |
Furong Liu, Zhibin Liao, Jia Song, Chaoyi Yuan, Yachong Liu, Hongwei Zhang, Yonglong Pan, Zhanguo Zhang, Bixiang Zhang. Genome‐wide screening diagnostic biomarkers and the construction of prognostic model of hepatocellular carcinoma. Journal of Cellular Biochemistry 2020; 121(3): 2582 doi: 10.1002/jcb.29480
|
| 21 |
Yan Jiao, Yanqing Li, Peiqiang Jiang, Zhuo Fu, Yahui Liu. High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56476-x
|
| 22 |
Arely Rosas-Cruz, Nohemí Salinas-Jazmín, Marco A. Velasco- Velázquez. Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?. Technology in Cancer Research & Treatment 2021; 20: 153303382110279 doi: 10.1177/15330338211027913
|
| 23 |
Sinem Nalbantoglu, Abdullah Karadag. Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics. Journal of Pharmaceutical and Biomedical Analysis 2021; 199: 114031 doi: 10.1016/j.jpba.2021.114031
|
| 24 |
Shuji Akimoto, Hiroyuki Tahara, Senichiro Yanagawa, Kentaro Ide, Yuka Tanaka, Tsuyoshi Kobayashi, Hideki Ohdan. Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma. Cancer Reports 2023; 6(8) doi: 10.1002/cnr2.1831
|
| 25 |
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 2023; 28(6): 101137 doi: 10.1016/j.aohep.2023.101137
|
| 26 |
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
|
| 27 |
Zachary J. Brown, Tim F. Greten. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 239 doi: 10.1007/978-3-030-21540-8_12
|
| 28 |
Hongxi Ma, Chunchun Huang, Qiuhuan Huang, Guangzhi Li, Jun Li, Bin Huang, Qiuhong Zhong, Cong Cao. Circular RNA circ_0014717 Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating miR-668-3p/BTG2 Axis. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.592884
|
| 29 |
Nicole Golob-Schwarzl, Sonja Kessler, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; : 119 doi: 10.1007/978-3-319-53661-3_6
|
| 30 |
Olfat Al-Harazi, Ibrahim H. Kaya, Maha Al-Eid, Lina Alfantoukh, Ali Saeed Al Zahrani, Mohammed Al Sebayel, Namik Kaya, Dilek Colak. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.710049
|
| 31 |
Dan Wang, Xiaojing Zhang, Yapeng Lu, Xueting Wang, Li Zhu. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. Pathology - Research and Practice 2018; 214(12): 1987 doi: 10.1016/j.prp.2018.09.007
|
| 32 |
Bita Moudi, Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb. The Study of Menin Expression as a Diagnostic Factor in HBV-Related Hepatocellular Carcinoma. Archives of Clinical Infectious Diseases 2020; 14(6) doi: 10.5812/archcid.88188
|
| 33 |
Hasan Çağrı Yıldırım, Gozde Kavgaci, Elvin Chalabiyev, Omer Dizdar. Advances in the Early Detection of Hepatobiliary Cancers. Cancers 2023; 15(15): 3880 doi: 10.3390/cancers15153880
|
| 34 |
Zheng Li, Haijie Xu, Jiaming Yu, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Liyan Xu, Enmin Li, Yuhui Peng, Yiwei Xu. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Cancer Control 2021; 28: 107327482110048 doi: 10.1177/10732748211004883
|
| 35 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
| 36 |
Shan Lu, Xinkui Liu, Chao Wu, Jingyuan Zhang, Antony Stalin, Zhihong Huang, Yingying Tan, Zhishan Wu, Leiming You, Peizhi Ye, Changgeng Fu, Xiaomeng Zhang, Jiarui Wu. Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis. Medicine 2023; 102(29): e33990 doi: 10.1097/MD.0000000000033990
|
| 37 |
Thomas Karlas, Valentin Blank, Albrecht Böhlig. Diagnostic Value of Ultrasound in Fatty Liver Disease. Ultraschall in der Medizin - European Journal of Ultrasound 2021; 42(02): 128 doi: 10.1055/a-1352-4313
|
| 38 |
Benjamin Koh, Pojsakorn Danpanichkul, Meng Wang, Darren Jun Hao Tan, Cheng Han Ng. Application of artificial intelligence in the diagnosis of hepatocellular carcinoma. eGastroenterology 2023; 1(2): e100002 doi: 10.1136/egastro-2023-100002
|
| 39 |
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Silvia Del Ry. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression. Clinical & Experimental Metastasis 2022; 39(4): 589 doi: 10.1007/s10585-022-10164-9
|
| 40 |
Yin-Qiao Liu, Ling-Yu Chu, Tian Yang, Biao Zhang, Zheng-Tan Zheng, Jian-Jun Xie, Yi-Wei Xu, Wang-Kai Fang. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. Bioscience Reports 2022; 42(5) doi: 10.1042/BSR20212612
|
| 41 |
Haidong Zhang, Xuanlong Du, Hui Dong, Wenjing Xu, Pengcheng Zhou, Shiwei Liu, Xin Qing, Yu Zhang, Meng Yang, Yewei Zhang. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02424-5
|
| 42 |
Jun Zhou, Gonghao Ling, Jia Cao, Xun Ding, Xingnan Liao, Meng Wu, Xinyu Zhou, Haibo Xu, QingYun Long. <p>Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma</p>. International Journal of Nanomedicine 2020; : 1373 doi: 10.2147/IJN.S233989
|
| 43 |
Lei Yao, Jun Li, Bo Jiang, Zeyu Zhang, Xinying Li, Xiwu Ouyang, Yao Xiao, Guodong Liu, Zhiming Wang, Gewen Zhang. RNF2 inhibits E-Cadherin transcription to promote hepatocellular carcinoma metastasis via inducing histone mono-ubiquitination. Cell Death & Disease 2023; 14(4) doi: 10.1038/s41419-023-05785-1
|
| 44 |
Yanping Zhang, Wanwen Lao, Kaming Yang, Xinyi Kong, Yuetong Li, Xin Yu, Xumeng Wang, Yang Liu, Zhenlin Li, Yilin Deng, Shuping Nie, Changlong Bi, Chao Wu, Aixia Zhai. SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11633-4
|
| 45 |
Jun-feng Sun. Roles of Circular RNAs And Their Interactions With MicroRNAs in Human Disorders. Clinical surgery research communications 2018; 2(2) doi: 10.31491/CSRC.2018.6.012
|
| 46 |
Heng Liang Tan, Andre Choo. Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets. International Journal of Molecular Sciences 2019; 20(22): 5752 doi: 10.3390/ijms20225752
|
| 47 |
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
|
| 48 |
Meiying Long, Zihan Zhou, Xueyan Wei, Qiuling Lin, Moqin Qiu, Yunxiang Zhou, Peiqin Chen, Yanji Jiang, Qiuping Wen, Yingchun Liu, Runwei Li, Xianguo Zhou, Hongping Yu. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1023349
|
| 49 |
Jiyun Zhang, Zhizhen Lai, Rui Ding, Jinyu zhou, Zhonghao Yuan, Dan Li, Xuzhen Qin, Jiang Zhou, Zhili li. Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases. Clinica Chimica Acta 2023; 539: 175 doi: 10.1016/j.cca.2022.12.015
|
| 50 |
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, Naotaka Shimozato, Kosuke Kaji, Yuki Tsuji, Keisuke Nakanishi, Ryuichi Noguchi, Yukihisa Fujinaga, Yasuhiko Sawada, Soichiro Saikawa, Shinya Sato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Hitoshi Yoshiji. Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. World Journal of Gastrointestinal Oncology 2019; 11(10): 887-897 doi: 10.4251/wjgo.v11.i10.887
|
| 51 |
Quynh Hoa Tran, Van Gio Nguyen, Cong Manh Tran, Minh Nam Nguyen. Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma. Heliyon 2021; 7(3): e06463 doi: 10.1016/j.heliyon.2021.e06463
|
| 52 |
An‐Li Jin, Yi‐Hui Yang, Xi Su, Wen‐Jing Yang, Te Liu, Wei Chen, Tong Li, Lin Ding, Hao Wang, Bei‐Li Wang, Bai‐Shen Pan, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo. High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(3) doi: 10.1002/jcla.24259
|
| 53 |
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
|
| 54 |
Craig C Teerlink, Chad Huff, Jeff Stevens, Yao Yu, Sheri L Holmen, Mark R Silvis, Kirby Trombetti, Hua Zhao, Douglas Grossman, James M Farnham, Jingran Wen, Julio C Facelli, Alun Thomas, Markus Babst, Scott R Florell, Laurence Meyer, John J Zone, Sancy Leachman, Lisa A Cannon-Albright. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. JNCI: Journal of the National Cancer Institute 2018; doi: 10.1093/jnci/djy058
|
| 55 |
Jung-Chen Ho, Meng-Lun Hsieh, Po-Heng Chuang, Vivian Chia-Rong Hsieh. Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Value in Health Regional Issues 2018; 15: 120 doi: 10.1016/j.vhri.2017.12.012
|
| 56 |
Chuanwen Yu, Chuang Sun, Shangxiang Chen. Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6581127
|
| 57 |
Xiaogang Dong, Wei Ding, Jianwei Ye, Dong Yan, Feng Xue, Lin Xu, Jiwei Yin, Wenjia Guo. MiR‐24‐3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochemistry and Function 2016; 34(7): 491 doi: 10.1002/cbf.3213
|
| 58 |
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2016; : 1 doi: 10.1080/1354750X.2016.1252966
|
| 59 |
Mengtao Xing, Xinzhi Wang, Robert Kirken, Ling He, Jian-Ying Zhang. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences 2021; 22(11): 6139 doi: 10.3390/ijms22116139
|
| 60 |
Simona Cernea, Danusia Onișor. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(2): 286-309 doi: 10.3748/wjg.v29.i2.286
|
| 61 |
Felice De Stefano, Eduardo Chacon, Lilia Turcios, Francesc Marti, Roberto Gedaly. Novel biomarkers in hepatocellular carcinoma. Digestive and Liver Disease 2018; 50(11): 1115 doi: 10.1016/j.dld.2018.08.019
|
| 62 |
Chang‐Hai Liu, Antonio Gil‐Gómez, Javier Ampuero, Manuel Romero‐Gómez. Diagnostic accuracy of SCCA and SCCA‐IgM for hepatocellular carcinoma: A meta‐analysis. Liver International 2018; 38(10): 1820 doi: 10.1111/liv.13867
|
| 63 |
Shuai Chen, Liming Tang, Adrien Guillot, Hanyang Liu. Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression. Metabolites 2022; 13(1): 11 doi: 10.3390/metabo13010011
|
| 64 |
Philip M. Hemken, Lori J. Sokoll, Xiaoqing Yang, Jianliang Dai, Debra Elliott, Susan H. Gawel, Michael Lucht, Ziding Feng, Jorge A. Marrero, Sudhir Srivastava, Daniel W. Chan, Gerard J. Davis. Validation of a novel model for the early detection of hepatocellular carcinoma. Clinical Proteomics 2019; 16(1) doi: 10.1186/s12014-018-9222-0
|
| 65 |
Mu-Sheng Zeng. The Long and Short Non-coding RNAs in Cancer Biology. Advances in Experimental Medicine and Biology 2016; 927: 391 doi: 10.1007/978-981-10-1498-7_15
|
| 66 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|
| 67 |
Manuela Cabiati, Nicoletta Di Giorgi, Costanza Salvadori, Francesco Finamore, Serena Del Turco, Antonella Cecchettini, Silvia Rocchiccioli, Silvia Del Ry. Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles. Pathology - Research and Practice 2022; 238: 154088 doi: 10.1016/j.prp.2022.154088
|
| 68 |
Jung Woo Eun, Jeong Won Jang, Hee Doo Yang, Jooyoung Kim, Sang Yean Kim, Min Jeong Na, Eunbi Shin, Jin Woong Ha, Soyoung Jeon, Young Min Ahn, Won Sang Park, Suk Woo Nam. Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma. Journal of Clinical Medicine 2022; 11(8): 2128 doi: 10.3390/jcm11082128
|
| 69 |
Daniel F Lyman, Amanda Bell, Alyson Black, Hayley Dingerdissen, Edmund Cauley, Nikhita Gogate, David Liu, Ashia Joseph, Robel Kahsay, Daniel J Crichton, Anand Mehta, Raja Mazumder. Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model. Glycobiology 2022; doi: 10.1093/glycob/cwac046
|
| 70 |
Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.604540
|
| 71 |
Zhenjie Li, Lisha Mou, Haibin Gao, Yi Zeng, Xueyi Tang, Xuesong Deng, Zuhui Pu, Yong Ni, Yongqiang Zhan. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma. Medicine 2019; 98(32): e16725 doi: 10.1097/MD.0000000000016725
|
| 72 |
Dalia H. Abou-Elela, Eman Abdel Sameea, Tamer Fakhry. Assessment of the diagnostic role of annexin A2 (ANXA2) and insulin-like growth factor-1 as serum markers for hepatocellular carcinoma. Egyptian Liver Journal 2016; 6(1): 1 doi: 10.1097/01.ELX.0000481901.80695.e7
|
| 73 |
Tao Li, Yuanzi Yu, Juan Liu, Xiangguo Tian, Meng Kong, Lei Wu, Shaocan Tang, Shengqing Gu, Jingfang Zhao, Yi Cui, Jinhua Hu. PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0229-6
|
| 74 |
Xiaojun Luo, Yang Wang, Xi Zhang, Wenbin Liu, Zhongjie Shi. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5735462
|
| 75 |
Anping Song, Tingting Ding, Na Wei, Jieren Yang, Mingyue Ma, Shuguo Zheng, Huanhuan Jin. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity. Toxicology and Applied Pharmacology 2023; 472: 116574 doi: 10.1016/j.taap.2023.116574
|
| 76 |
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022; 12(5): 342 doi: 10.3390/bios12050342
|
| 77 |
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin. Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2019; 116: 108852 doi: 10.1016/j.biopha.2019.108852
|
| 78 |
Jun Ho Lee, Jae Hee Suh, Soo Youn Choi, Hyun Je Kang, Hwan Hee Lee, Byeong Jin Ye, Gap Ryol Lee, Seok Won Jung, Chang Jae Kim, Whaseon Lee-Kwon, Jiyoung Park, Kyungjae Myung, Neung Hwa Park, Hyug Moo Kwon. Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis. Gut 2019; 68(2): 347 doi: 10.1136/gutjnl-2017-315348
|
| 79 |
Muthaiyan Ahalliya Rathi, Elliangal Kunhappa Girisan, Velliyur Kanniappan Gopalakrishnan, Periasamy Meenakshi, Dugganaboyana Guru Kumar. Nanomaterials for Energy Conversion, Biomedical and Environmental Applications. Materials Horizons: From Nature to Nanomaterials 2022; : 255 doi: 10.1007/978-981-19-2639-6_11
|
| 80 |
Chao Han, Lanzhu Gao, Han Bai, Xiaoguang Dou. Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9547
|
| 81 |
Li Huang, Zhuning Mo, Zuojian Hu, Linyan Zhang, Shanzi Qin, Xue Qin, Shan Li. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1161-y
|
| 82 |
Changzheng Li, Jie Chen, Yishan Li, Binghuo Wu, Zhitao Ye, Xiaobin Tian, Yan Wei, Zechen Hao, Yuan Pan, Hongli Zhou, Keyue Yang, Zhiqiang Fu, Jingbo Xu, Yanan Lu. 6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.753196
|
| 83 |
Hu Liang, Ji Ai-Jun, Zhang Ji-Zong, Han Jian-Bo, Zhao Liang, Yi Yong-Xiang, Yu Chen. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma. Anti-Cancer Drugs 2019; 30(2): 186 doi: 10.1097/CAD.0000000000000711
|
| 84 |
Ye Xu, Qinglong Guo, Libin Wei. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(20): 5096 doi: 10.3390/cancers13205096
|
| 85 |
Zhipeng Tang, Pei Zhao, Wanxing Zhang, Qian Zhang, Ming Zhao, He Tan. SALL4 activates PI3K/AKT signaling pathway through targeting PTEN, thus facilitating migration, invasion and proliferation of hepatocellular carcinoma cells. Aging 2022; 14(24): 10081 doi: 10.18632/aging.204446
|
| 86 |
Jingnuo Ding, Weifeng Zhao. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma. Cancer Management and Research 2022; : 2735 doi: 10.2147/CMAR.S373165
|
| 87 |
Abdulrahman Al-Shami, Rami Joseph Oweis, Mohamed Ghazi Al-Fandi. Developing an electrochemical immunosensor for early diagnosis of hepatocellular carcinoma. Sensor Review 2021; 41(2): 125 doi: 10.1108/SR-02-2020-0030
|
| 88 |
Duan Xie, Dongxia Li, Fangrong Hu, Zhiyou Wang, Longhui Zhang, Mingzhu Jiang, Yuanli Wang. Terahertz Metamaterial Biosensor With Double Resonant Frequencies for Specific Detection of Early-Stage Hepatocellular Carcinoma. IEEE Sensors Journal 2023; 23(2): 1124 doi: 10.1109/JSEN.2022.3225344
|
| 89 |
Ting Wang, Kun-He Zhang, Piao-Ping Hu, Zeng-Yong Huang, Pan Zhang, Qin-Si Wan, De-Qiang Huang, Nong-Hua Lv. Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests. Oncotarget 2016; 7(39): 64053 doi: 10.18632/oncotarget.11771
|
| 90 |
Egisto Boschetti, Alfonsina D'Amato, Giovanni Candiano, Pier Giorgio Righetti. Protein biomarkers for early detection of diseases: The decisive contribution of combinatorial peptide ligand libraries. Journal of Proteomics 2018; 188: 1 doi: 10.1016/j.jprot.2017.08.009
|
| 91 |
Andem Effiong, Prerna Kumari. Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol). Systematic Reviews 2018; 7(1) doi: 10.1186/s13643-018-0688-7
|
| 92 |
Mona Moussa, Noha Helal, Enas Elnahas, Samar El-Sheikh, Dalal Alwi. Correlation of hepatic expression of Ki-67 and metallothionein with iron load in chronic hepatitis C and hepatocellular carcinoma. Current Medicine Research and Practice 2018; 8(6): 209 doi: 10.1016/j.cmrp.2018.10.002
|
| 93 |
Xiumei Wang, Weiwei Zhang, Youde Liu, Wenjing Gong, Ping Sun, Xiangshuo Kong, Miaomiao Yang, Zhihua Wang. Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0153-6
|
| 94 |
天柱 吴. Research Trends of Artificial Intelligence in Liver Cancer: A Bibliometric Analysis. Advances in Clinical Medicine 2023; 13(04): 6457 doi: 10.12677/ACM.2023.134907
|
| 95 |
Lorella Maniscalco, Katia Varello, Simona Zoppi, Giuseppina Abbamonte, Marta Ferrero, Elena Torres, Federica Ostorero, Francesca Rossi, Elena Bozzetta. Abnormal Prothrombin (PIVKA-II) Expression in Canine Tissues as an Indicator of Anticoagulant Poisoning. Animals 2021; 11(9): 2612 doi: 10.3390/ani11092612
|
| 96 |
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study. Hepatology Communications 2022; 6(4): 679 doi: 10.1002/hep4.1847
|
| 97 |
Andrew DelaCourt, Alyson Black, Peggi Angel, Richard Drake, Yujin Hoshida, Amit Singal, David Lewin, Bachir Taouli, Sara Lewis, Myron Schwarz, M. Isabel Fiel, Anand S. Mehta. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. Molecular Cancer Research 2021; 19(11): 1868 doi: 10.1158/1541-7786.MCR-21-0348
|
| 98 |
Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson, Stephen Palmer. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technology Assessment 2021; 25(76): 1 doi: 10.3310/hta25760
|
| 99 |
Xi-wu Zhang, Qiu-han Li, Zuo-di Xu, Jin-jin Dou. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03300-4
|
| 100 |
Yanlin Jin, Yi Zhang, Xiaoming Luo. circRNA_PTPRA functions as a sponge of miR‑582‑3p to regulate hepatocellular carcinoma cell proliferation, migration, invasion and apoptosis. Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10711
|
| 101 |
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
|
| 102 |
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
|
| 103 |
Jingjing Zong, Zhe Fan, Yewei Zhang. <p>Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma</p>. Journal of Hepatocellular Carcinoma 2020; : 413 doi: 10.2147/JHC.S272762
|
| 104 |
Xiaoting Song, Ailu Wu, Zhixiao Ding, Shixiong Liang, Chunyan Zhang. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Cancer Research and Treatment 2020; 52(3): 789 doi: 10.4143/crt.2019.749
|
| 105 |
Xiao Wang, Ran Sun, Na Che, Danfang Zhang, Yanlei Li, Nan Zhao. Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT. Digestive and Liver Disease 2024; doi: 10.1016/j.dld.2024.01.182
|
| 106 |
Jinping Li, Sheng Zhao, Zaisheng Ling, Daqing Li, Guangsheng Jia, Chenglei Zhao, Xue Lin, Yanmei Dai, Huijie Jiang, Song Wang, Yuvaraja Teekaraman. Dual-Energy Computed Tomography Imaging in Early-Stage Hepatocellular Carcinoma: A Preliminary Study. Contrast Media & Molecular Imaging 2022; 2022: 1 doi: 10.1155/2022/2146343
|
| 107 |
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5087643
|
| 108 |
Akiko Eguchi, Motoh Iwasa, Yasuyuki Tamai, Minori Yamada, Koji Okuno, Ryuta Shigefuku, Kyoko Yoshikawa, Mina Tempaku, Koji Sakaguchi, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, Tetsuji Yamaguchi, Hayato Nakagawa. The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.993705
|
| 109 |
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2): 586 doi: 10.3390/biomedicines11020586
|
| 110 |
Mingshuang Lai, Deyuan Li, Meiliang Liu, Ruirui Zhang, Lijun Wang, Wenyi Peng, Haotian Xu, Siqian Wu, Si Liang, Ye Gu, Aruo Nan, Xiaoyun Zeng. CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR‐630/HHIP axis. Cancer Medicine 2023; 12(11): 12553 doi: 10.1002/cam4.5894
|
| 111 |
Shuping Zhou, Juan Wei, Yeliu Wang, Xinkuang Liu. Cisplatin resistance‑associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8526
|
| 112 |
Mi Zhang, Wei Zhao, Shanshan Liu, Haichuan Liu, Liang Liu, Qiling Peng, Chengyou Du, Ning Jiang. H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 2021; : 1331 doi: 10.2147/PGPM.S333838
|
| 113 |
Ayman F. El-Shayeb, Nihal M. El-Habachi, Amal R. Mansour, Mariam S. Zaghloul. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients. Medicine 2021; 100(17): e25112 doi: 10.1097/MD.0000000000025112
|
| 114 |
Connor A. West, Alyson P. Black, Anand S. Mehta. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 93 doi: 10.1007/978-3-030-21540-8_5
|
| 115 |
Yingshi Zhang, Jiayue Gao, Yu Bao, Yang Liu, Yimeng Tong, Shuqing Jin, Qingchun Zhao. Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis. Biomarkers 2022; 27(1): 13 doi: 10.1080/1354750X.2021.2008009
|
| 116 |
Ke Su, Weihong Huang, Xueting Li, Ke Xu, Tao Gu, Yanlin Liu, Juan Song, Keyi Qian, Yaoyang Xu, Hao Zeng, Yipei Yang, Lu Guo, Yunwei Han. Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of Hepatocellular Carcinoma 2023; : 69 doi: 10.2147/JHC.S398632
|
| 117 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
|
| 118 |
Yongchang Zheng, Qianqian Huang, Zijian Ding, Tingting Liu, Chenghai Xue, Xinting Sang, Jin Gu. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma. Briefings in Bioinformatics 2016; : bbw094 doi: 10.1093/bib/bbw094
|
| 119 |
Ying Zhao, Jinmei Yao. The Biological Functions and Clinical Values of Exosomal Circular RNAs in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.885214
|
| 120 |
Yu Wang, Bin-hui Xie, Wei-hao Lin, Yong-hui Huang, Jia-yan Ni, Jie Hu, Wei Cui, Jun Zhou, Long Shen, Lin-feng Xu, Fan Lian, He-ping Li. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene 2019; 38(25): 4948 doi: 10.1038/s41388-019-0766-x
|
| 121 |
Muhammad Afzal, Muhammad Imran, Samen Fatima, Muhammad Iqbal, Farkhanda Gillani, Nayyar Rubab, Owais Gill, Muhammad Naeem. 99mTc-MDP renal parenchymal retention on bone scan in hepatocellular carcinoma patients. Pakistan Journal of Nuclear Medicine 2020; : 31 doi: 10.24911/PJNMed.175-1574674085
|
| 122 |
Raghda Saad Zaghloul Taleb, Ahmed Elsayed Zeid, Maha Ahmed Nabil, Pacint Elsayed Moez. Plasma Long Non-Coding RNA ZFAS1 as a Potential Diagnostic Biomarker for HCV-Related Hepatocellular Carcinoma. Molecular Genetics, Microbiology and Virology 2022; 37(4): 242 doi: 10.3103/S0891416822040061
|
| 123 |
Qian-Hui Xu, Qing Yuan, Yu-Qing Zhang, Biao Li, You-Lan Min, Qian-Min Ge, Rong-Bin Liang, Yi Shao. Ocular Metastasis in Elderly Male Bladder Cancer Patients: Potential Risk Factors. American Journal of Men's Health 2020; 14(2): 155798832090899 doi: 10.1177/1557988320908998
|
| 124 |
Longqiu Yang, Pengcheng Luo, Qiong Song, Xuejie Fei. DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation. Biomedicine & Pharmacotherapy 2018; 99: 839 doi: 10.1016/j.biopha.2018.01.161
|
| 125 |
Wenbiao Chen, Minglin Ou, Donge Tang, Yong Dai, Weibo Du. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/5494858
|
| 126 |
Moustafa A. Sakr, Mahmood A. Al-Azzawi, Anis Anis, Amal A. Abd El-Aziz, Mohamed E. Ebeid, Mahmoud A. Shokeer, Aysam fayed. The correlation between P53 and COX-2 expression and the pathological alteration in hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00230-y
|
| 127 |
Pengfei Li, Zhen Liu. Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives. Chemical Society Reviews 2024; 53(4): 1870 doi: 10.1039/D3CS00842H
|
| 128 |
AM Attallah, MS Albannan, MS El-Deen, K Farid, FM Khedr, KA Attallah, SO Abdallah. Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma. British Journal of Biomedical Science 2020; 77(2): 58 doi: 10.1080/09674845.2019.1708534
|
| 129 |
Tian Yang, Hao Xing, Guoqiang Wang, Nianyue Wang, Miaoxia Liu, Cunling Yan, Huijun Li, Lianhua Wei, Shunjun Li, Zhuping Fan, Ming Shi, Wei Chen, Shangli Cai, Timothy M Pawlik, Andrew Soh, Agim Beshiri, Wan Yee Lau, Mengchao Wu, Yijie Zheng, Feng Shen. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. Clinical Chemistry 2019; 65(12): 1543 doi: 10.1373/clinchem.2019.308965
|
| 130 |
Zeribe C. Nwosu, Nadia Battello, Melanie Rothley, Weronika Piorońska, Barbara Sitek, Matthias P. Ebert, Ute Hofmann, Jonathan Sleeman, Stefan Wölfl, Christoph Meyer, Dominik A. Megger, Steven Dooley. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0872-6
|
| 131 |
Besnik Muqaku, Martin Eisinger, Samuel M. Meier, Ammar Tahir, Tobias Pukrop, Sebastian Haferkamp, Astrid Slany, Albrecht Reichle, Christopher Gerner. Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma. Molecular & Cellular Proteomics 2017; 16(1): 86 doi: 10.1074/mcp.M116.063313
|
| 132 |
Mo Cheng, Xiufeng Zheng, Jing Wei, Ming Liu. Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review). Experimental and Therapeutic Medicine 2023; 26(6) doi: 10.3892/etm.2023.12285
|
| 133 |
Christiana Christou, Andreas Stylianou, Vasiliki Gkretsi. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker. Cells 2024; 13(2): 136 doi: 10.3390/cells13020136
|
| 134 |
Wenhua Hu, Wei Ge, Peng Xia, Yan Chen, Jing Du, Guangxu Hu, Zhen Wu, Xumin Zhang, Chuanlai Yang, Junhong Jiang, Shuang Yang, Jun Xia. Diagnostic Potential of Serum Glycome Analysis in Lung Cancer: A Glycopattern Study. Journal of Proteome Research 2024; 23(1): 500 doi: 10.1021/acs.jproteome.3c00645
|
| 135 |
Zifei Wang, Yu Zhong, Zefan Zhang, Kaiqian Zhou, Zhihao Huang, Hao Yu, Longqi Liu, Shiping Liu, Huanming Yang, Jian Zhou, Jia Fan, Liang Wu, Yunfan Sun. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847263
|
| 136 |
Mingfang Ji, Zhiwei Liu, Ellen T. Chang, Xia Yu, Biaohua Wu, Li Deng, Qianjin Feng, Kuangrong Wei, Xuejun Liang, Shifeng Lian, Wen Quan, Panpan Wang, Yun Du, Zhiheng Liang, Shenglin Xia, Hai Lin, Fugui Li, Weimin Cheng, Weiqiang Chen, Yong Yuan, Weimin Ye. Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31119-9
|
| 137 |
Tony El Jabbour, Stephen M Lagana, Hwajeong Lee. Update on hepatocellular carcinoma: Pathologists’ review. World Journal of Gastroenterology 2019; 25(14): 1653-1665 doi: 10.3748/wjg.v25.i14.1653
|
| 138 |
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers. Diagnostics 2023; 13(8): 1442 doi: 10.3390/diagnostics13081442
|
| 139 |
Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/5484976
|
| 140 |
Qingqing Lv, Zhaoyu Zhang, Haijuan Fu, Danyang Li, Yihao Liu, Yingnan Sun, Minghua Wu. Predictive Panel for Immunotherapy in Low-Grade Glioma. World Neurosurgery 2024; 183: e825 doi: 10.1016/j.wneu.2024.01.039
|
| 141 |
Maria Papanastasatou, Mihalis Verykokakis. Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1114605
|
| 142 |
Hyunsoo Kim, Areum Sohn, Injoon Yeo, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring–Mass Spectrometry for Diagnosing Hepatocellular Carcinoma. Clinical Chemistry 2018; 64(8): 1230 doi: 10.1373/clinchem.2018.289702
|
| 143 |
Ting Wang, Kun-He Zhang, Piao-Ping Hu, Qin-Si Wan, Fang-Li Han, Jian-Ming Zhou, De-Qiang Huang, Nong-Hua Lv. Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases. Oncotarget 2017; 8(58): 97758 doi: 10.18632/oncotarget.22050
|
| 144 |
Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.686962
|
| 145 |
Manuela Cabiati, Melania Gaggini, Maria Michela Cesare, Chiara Caselli, Paolo De Simone, Franco Filipponi, Giuseppina Basta, Amalia Gastaldelli, Silvia Del Ry. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up. Cytokine 2017; 99: 59 doi: 10.1016/j.cyto.2017.07.004
|
| 146 |
Bashdar Mahmud Hussen, Kasra Honarmand Tamizkar, Hazha Jamal Hidayat, Mohammad Taheri, Soudeh Ghafouri-Fard. The role of circular RNAs in the development of hepatocellular carcinoma. Pathology - Research and Practice 2021; 223: 153495 doi: 10.1016/j.prp.2021.153495
|
| 147 |
Yanhong Chen, Jiao Zhang, Jia Liu, Jianguo Wang, Chao Shi, Lu Lu, Xing Cheng, Guoping Niu, Shuangshuang Zhang, Dawei Cui. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/1817694
|
| 148 |
Juanjun Huang, Xiaoli Chen, Wei Zhu. MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma. Medicine 2021; 100(12): e25234 doi: 10.1097/MD.0000000000025234
|
| 149 |
Peng Liu, Jinhong Wei, Feiyu Mao, Zechang Xin, Heng Duan, Yan Du, Xiaodong Wang, Zhennan Li, Jianjun Qian, Jie Yao. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.641487
|
| 150 |
Na Sun, Yi-Te Lee, Ryan Y. Zhang, Rueihung Kao, Pai-Chi Teng, Yingying Yang, Peng Yang, Jasmine J. Wang, Matthew Smalley, Pin-Jung Chen, Minhyung Kim, Shih-Jie Chou, Lirong Bao, Jing Wang, Xinyue Zhang, Dongping Qi, Juvelyn Palomique, Nicolas Nissen, Steven-Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Daniela Markovic, David Elashoff, Hsiao-hua Yu, Huiying Li, Anthony P. Heaney, Edwin Posadas, Sungyong You, Ju Dong Yang, Renjun Pei, Vatche G. Agopian, Hsian-Rong Tseng, Yazhen Zhu. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-18311-0
|
| 151 |
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim. Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. Cancers 2021; 14(1): 67 doi: 10.3390/cancers14010067
|
| 152 |
Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022; 14(19): 4647 doi: 10.3390/cancers14194647
|
| 153 |
Po-Shuan Huang, Cheng-Chih Chang, Chia-Siu Wang, Kwang-Huei Lin. Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer. Biomedical Journal 2021; 44(3): 272 doi: 10.1016/j.bj.2020.08.009
|
| 154 |
Wentao Zhu, Pei Shi, An Liang, Ying Zhu, Jiwei Fu, Songsong Yuan, Xiaoping Wu. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10139-9
|
| 155 |
Hua-guo Feng, Chuan-xin Wu, Guo-chao Zhong, Jian-ping Gong, Chun-mu Miao, Bin Xiong. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism. Journal of Cancer Research and Clinical Oncology 2023; 149(17): 15879 doi: 10.1007/s00432-023-05360-3
|
| 156 |
Chaowen Zheng, Peng Dai, Hui You, Zhaokun Xian, Wenyun Su, Shixiong Wu, Dong Xing, Cuimin Sun. A compact microfluidic laser-induced fluorescence immunoassay system using avalanche photodiode for rapid detection of alpha-fetoprotein. Analytical Sciences 2024; doi: 10.1007/s44211-024-00553-3
|
| 157 |
Feng Gong, Zhiyou Tan, Xiaoyun Shan, Yixia Yang, Songbai Tian, Fuxiang Zhou, Xinghu Ji, Zhike He. A Facile Strategy for Multiplex Protein Detection by a Fluorescent Microsphere-Based Digital Immunoassay. Analytical Chemistry 2024; 96(8): 3517 doi: 10.1021/acs.analchem.3c05336
|
| 158 |
Yinying Chen, Wei Yang, Qilong Chen, Qiong Liu, Jun Liu, Yingying Zhang, Bing Li, Dongfeng Li, Jingyi Nan, Xiaodong Li, Huikun Wu, Xinghua Xiang, Yehui Peng, Jie Wang, Shibing Su, Zhong Wang. Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02791-9
|
| 159 |
Francesco Dituri, Gianluigi Gigante, Rosanna Scialpi, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli. Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma. Cancers 2022; 14(8): 1902 doi: 10.3390/cancers14081902
|
| 160 |
Ahmed Musa Hago Bakheet, Chang Zhao, Jian-Ning Chen, Jing-Yue Zhang, Jun-Ting Huang, Yu Du, Li-Ping Gong, Yuan-Hua Bi, Chun-Kui Shao. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology. Hepatology International 2020; 14(1): 96 doi: 10.1007/s12072-019-10006-z
|
| 161 |
Tomonari Shimagaki, Sachiyo Yoshio, Hironari Kawai, Yuzuru Sakamoto, Hiroyoshi Doi, Michitaka Matsuda, Taizo Mori, Yosuke Osawa, Moto Fukai, Takeshi Yoshida, Yunfei Ma, Tomoyuki Akita, Junko Tanaka, Akinobu Taketomi, Rikinari Hanayama, Tomoharu Yoshizumi, Masaki Mori, Tatsuya Kanto. Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52356-6
|
| 162 |
Wen‐Yin Ko, Shin‐Chwen Yeh, Yun‐Chen Hsu, Hsiao‐Wen Chu, Kuan‐Jiuh Lin. A Flexible Broadband Visible Light Plasmon‐Absorber Based on a 2D Monolayer of Au‐Nanoparticle/TiO2‐Nanowire Core–Shell Heterostructures. Advanced Materials Interfaces 2023; 10(35) doi: 10.1002/admi.202300415
|
| 163 |
Binglin Cheng, Peitao Zhou, Yuhan Chen. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04805-9
|
| 164 |
Audrey Payancé, Marco Dioguardi Burgio, Katell Peoc’h, Mohamed Achahboun, Miguel Albuquerque, Julie Devictor, Hélène Chor, Hana Manceau, Olivier Soubrane, François Durand, Laurent Castera, Mohamed Bouattour, Valérie Paradis. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2020; 32(10): 1364 doi: 10.1097/MEG.0000000000001652
|
| 165 |
Lihua Lyu, Wenjing Yang, Jiayi Yao, Hao Wang, Jie Zhu, Anli Jin, Te Liu, Beili Wang, Jian Zhou, Jia Fan, Xinrong Yang, Wei Guo. The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma. Biomarkers in Medicine 2021; 15(5): 359 doi: 10.2217/bmm-2020-0476
|
| 166 |
Anthony Pellicano, Stephanie Mullan, Itzhak Goldberg, Prakash Narayan. Hepatic mRNA Expression Levels of the Oncogenes Alpha-Fetoprotein and Osteopontin as Diagnostics for Liver Cancer in a Murine Model of Diet-Induced Non-Alcoholic Steatohepatitis. Processes 2021; 9(9): 1516 doi: 10.3390/pr9091516
|
| 167 |
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. British Journal of Biomedical Science 2021; 78(1): 18 doi: 10.1080/09674845.2020.1778842
|
| 168 |
Won-Suk Song, Han-Gyu Park, Da-Hee Ann, Yoon-Yi Jeong, Mi-Young Koo, Yun-Gon Kim. Quantitative Analysis of Core-Fucosylated N-glycome according to Serum AFP Level for the Diagnosis of Hepatocellular Carcinoma. KSBB Journal 2017; 32(4): 279 doi: 10.7841/ksbbj.2017.32.4.279
|
| 169 |
Thanikan Sukaram, Rossarin Tansawat, Chonlada Phathong, Rungsun Rerknimitr, Roongruedee Chaiteerakij. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients. Clinica Chimica Acta 2024; 556: 117831 doi: 10.1016/j.cca.2024.117831
|
| 170 |
Xitian Liang, Bolin Wu, Haitao Shang, Xue Han, Hui Jing, Yixin Sun, Wen Cheng. VTIQ evaluates antitumor effects of NET‑1 siRNA by UTMD in HCC xenograft models. Oncology Letters 2018; doi: 10.3892/ol.2018.8994
|
| 171 |
Asma Sindhoo, Saima Sipy, Abbas Khan, Gurudeeban Selvaraj, Abdulrahman Alshammari, Mark Earl Casida, Dong-Qing Wei. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. Database 2023; 2023 doi: 10.1093/database/baad063
|
| 172 |
Kaida Huang, Yubiao Lin, Keyin Wang, Jianfen Shen, Dahai Wei. ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway. Journal of Hepatocellular Carcinoma 2022; : 1323 doi: 10.2147/JHC.S392056
|
| 173 |
Lijie Zhang, Joyman Makamure, Dan Zhao, Yiming Liu, Xiaopeng Guo, Chuansheng Zheng, Bin Liang. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV‑associated hepatocellular carcinoma. Experimental and Therapeutic Medicine 2020; 20(1): 427 doi: 10.3892/etm.2020.8722
|
| 174 |
Yifan Wang, Linling Ju, Feng Xiao, Hui Liu, Xi Luo, Lin Chen, Zhonghua Lu, Zhaolian Bian. Downregulation of nucleolar and spindle‑associated protein 1 expression suppresses liver cancer cell function. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7314
|
| 175 |
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S. Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V. Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A. Yamin, Itzhak D. Goldberg, Prakash Narayan, Mahesh Narayan. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. PLOS ONE 2018; 13(6): e0198937 doi: 10.1371/journal.pone.0198937
|
| 176 |
Mira Anne C. dela Rosa, Wei-Chun Chen, Yi-Ju Chen, Rofeamor P. Obena, Chih-Hsiang Chang, Rey Y. Capangpangan, Tung-Hung Su, Chi-Ling Chen, Pei-Jer Chen, Yu-Ju Chen. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature. Analytical Chemistry 2017; 89(7): 3973 doi: 10.1021/acs.analchem.6b04396
|
| 177 |
Feng Gao, Rui Zhang, Fang Ma, Bo Liu, Meng Zhang, Jihong Yang. Synthesis, characterization and application of ZnO and Ag-doped ZnO nanostructures against human liver cells (HepG2). A suitable candidate for valproate. Chemical Papers 2021; 75(5): 2191 doi: 10.1007/s11696-020-01456-z
|
| 178 |
Guitian He, Juntao Ding, Yong’e Zhang, Mengting Cai, Jing Yang, William C. Cho, Yadong Zheng. microRNA-21: a key modulator in oncogenic viral infections. RNA Biology 2021; 18(5): 809 doi: 10.1080/15476286.2021.1880756
|
| 179 |
Lanjing Zhang. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 95 doi: 10.1007/978-3-319-68082-8_6
|
| 180 |
Shao-hua Chen, Xu Wang. A high preoperative serum IL-25 level is a negative prognosis predictor after liver resection for HBV-HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858151
|
| 181 |
Qinggong Yuan, Yan Zhang, Junhui Li, Di Zhang, Wenbin Yang. Circ_TEX2 Functions as a Tumor Suppressor in Hepatoma via miR-96-5p/SPRED1 Axis. Molecular Biotechnology 2023; 65(10): 1679 doi: 10.1007/s12033-023-00669-3
|
| 182 |
Jiatao Lou, LingFei Zhang, Shaogang Lv, Chenzi Zhang, Shuai Jiang. Biomarkers for Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9: 1179299X1668464 doi: 10.1177/1179299X16684640
|
| 183 |
Yang Han, Zhe Li, Qi Wu, Hui Liu, Zhiqiang Sun, Yong Wu, Judong Luo. B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09442-2
|
| 184 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 185 |
P. Gunasekhar, S. Vijayalakshmi. Optimal biomarker selection using adaptive Social Ski-Driver optimization for liver cancer detection. Biocybernetics and Biomedical Engineering 2020; 40(4): 1611 doi: 10.1016/j.bbe.2020.10.005
|
| 186 |
Qingqing Lu, Jie Li, Hui Cao, Chenlu Lv, Xiaolin Wang, Shiqiong Cao. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20192424
|
| 187 |
Li-Yang Sun, Nan-Ya Wang, Yong-Kang Diao, Cun-Lin Yan, Zhu-Ping Fan, Lian-Hua Wei, Hui-Jun Li, Ming-Cheng Guan, Ming-Da Wang, Timothy M Pawlik, Wan Yee Lau, Feng Shen, Guo-Yue Lv, Tian Yang. Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score. Hepatobiliary & Pancreatic Diseases International 2023; doi: 10.1016/j.hbpd.2023.12.004
|
| 188 |
Mohamed S. Attia, Amal A. Mohamed, Mostafa M. El-Saady, Mona N. Abou-Omar, Hisham G. Afify, Tarek A. Amin, Ahmed H. Hosny, Ahmed O. Youssef, Mohamed S. Mohy-Eldin. A new method for early diagnosis of liver cancer using a biosensor embedded in an alginate polymer thin film. Journal of Materials Chemistry C 2022; 10(16): 6464 doi: 10.1039/D2TC00209D
|
| 189 |
Dejun Li, Shengnan Jia, Shuyue Wang, Lianghai Hu. Glycoproteomic Analysis of Urinary Extracellular Vesicles for Biomarkers of Hepatocellular Carcinoma. Molecules 2023; 28(3): 1293 doi: 10.3390/molecules28031293
|
| 190 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6): 1493 doi: 10.3390/cancers14061493
|
| 191 |
Erick Thokerunga, Peter Kisembo, Huang FangFang, Wang Zi, Zhang Yu, Christian Cedrick Bongolo, Jiancheng Tu. Serum Midkine for AFP-negative hepatocellular carcinoma diagnosis: a systematic review and meta-analysis. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00259-7
|
| 192 |
Rishila Ghosh, Rakin Ahmed, Hafiz Ahmed, Bishnu P. Chatterjee. Phosphorylated Proteins from Serum: A Promising Potential Diagnostic Biomarker of Cancer. International Journal of Molecular Sciences 2022; 23(20): 12359 doi: 10.3390/ijms232012359
|
| 193 |
Rui Duan, Caiyan Li, Fan Wang, Fei Han, Ling Zhu. <p>The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway</p>. OncoTargets and Therapy 2020; : 4431 doi: 10.2147/OTT.S246278
|
| 194 |
Sivesh K. Kamarajah, Timothy L. Frankel, Christopher Sonnenday, Clifford S. Cho, Hari Nathan. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis. Journal of Surgical Oncology 2018; 117(4): 644 doi: 10.1002/jso.24908
|
| 195 |
Marco Cagnin, Alessandra Biasiolo, Andrea Martini, Mariagrazia Ruvoletto, Santina Quarta, Silvano Fasolato, Paolo Angeli, Giorgio Fassina, Patrizia Pontisso. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56633-2
|
| 196 |
Kwadwo Apeadu Danso, Rosemary Sefakor Akuaku, Rebekah Ruth Taylor, Emmanuella Amoako, Kofi Ulzen‐Appiah, Bashiru Babatunde Jimah, Lily Gloria Tagoe. A case report of a teenager with hepatitis B surface antigen‐positive multifocal hepatocellular carcinoma in a noncirrhotic liver. Clinical Case Reports 2022; 10(3) doi: 10.1002/ccr3.5622
|
| 197 |
Hang Tuo, Yufeng Wang, Liang Wang, Bowen Yao, Qing Li, Cong Wang, Zhikui Liu, Shaoshan Han, Guozhi Yin, Kangsheng Tu, Qingguang Liu. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma. Oncotarget 2017; 8(39): 65687 doi: 10.18632/oncotarget.20058
|
| 198 |
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07916-3
|
| 199 |
Ran Xue, Jiliang Feng, Qinghua Meng, Fudong Lv, Yueke Zhu, Hongwei Yu, Shijie Zhang, Chenzhao Song, Lin Sun, Zhujun Yue, Shuai Feng, Ruiwen Che, Qian Xiang, Xiaodan Jing. The significance of glypican‐3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression. Journal of Gastroenterology and Hepatology 2017; 32(8): 1503 doi: 10.1111/jgh.13736
|
| 200 |
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma. World Journal of Meta-Analysis 2019; 7(3): 80-95 doi: 10.13105/wjma.v7.i3.80
|
| 201 |
Muhammad Kamran, Aimun Raees, Wasim Jafri. Updates on the Diagnosis and Management of Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology 2021; 11(1): 32 doi: 10.5005/jp-journals-10018-1335
|
| 202 |
Shuo Zhu, Shengya Cao, Weibin Yang, Jinhui Che, Deqiang Li, Ruifeng Pei, Yiren Ding. The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1. Cancer Management and Research 2021; : 5751 doi: 10.2147/CMAR.S304125
|
| 203 |
Haixiang Xie, Chongjiu Qin, Xin Zhou, Junqi Liu, Kejian Yang, Jusen Nong, Jianzhu Luo, Tao Peng. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma. Medicine 2023; 102(33): e34765 doi: 10.1097/MD.0000000000034765
|
| 204 |
Ying-jie Gao, Shi-rong Li, Yuan Huang. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1118152
|
| 205 |
Tasneem A. Gameel, Sherine Rady, Khaled A. ElBahnasy, Sanaa M. Kamal. Novel Biomarkers from genes in the apoptotic pathway for Prediction of HCC Progression using Association Rule Mining. Proceedings of the 2019 8th International Conference on Software and Information Engineering 2019; : 217 doi: 10.1145/3328833.3328863
|
| 206 |
Xiaoyun Bin, Yu Luo, Zefeng Sun, Chaoqun Lin, Peng Huang, Zhenbo Tu, Ling Li, Cong Qu, Jiamin Long, Sufang Zhou. The Role of H2-Calponin Antigen in Cancer Metastasis: Presence of Autoantibodies in Liver Cancer Patients. International Journal of Molecular Sciences 2023; 24(12): 9864 doi: 10.3390/ijms24129864
|
| 207 |
Yixi Li, Zhimou Mei, Liang Shi, Yin Wan, Xiaoli Zhou, Ting Zeng, Yi Liu, Jia Yao Yang, Zhaohong Shi. Evaluation of bevacizumab biosimilar on wound healing complications in patients with colorectal cancer undergoing endoscopic mucosal resection: A systematic review and meta‐analysis in anorectal medicine. International Wound Journal 2024; 21(1) doi: 10.1111/iwj.14638
|
| 208 |
Weiyi Wang, Chao Wei. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases 2020; 7(3): 308 doi: 10.1016/j.gendis.2020.01.014
|
| 209 |
Kailiang Zhao, Xiaoquan Zhou, Yuchun Xiao, Yanni Wang, Lu Wen. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer. Mini-Reviews in Medicinal Chemistry 2022; 22(17): 2237 doi: 10.2174/1389557522666220218124816
|
| 210 |
Naoki Yagi, Toshihiro Suzuki, Shoichi Mizuno, Motohiro Kojima, Masashi Kudo, Motokazu Sugimoto, Shin Kobayashi, Naoto Gotohda, Genichiro Ishii, Tetsuya Nakatsura. Component with abundant immune‐related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis. Cancer Science 2022; 113(5): 1564 doi: 10.1111/cas.15313
|
| 211 |
Ting Song, Lili Wang, Bin Su, Weiping Zeng, Taiyi Jiang, Tong Zhang, Guizhen Sun, Hao Wu. Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma. Journal of International Medical Research 2020; 48(3): 030006051988927 doi: 10.1177/0300060519889270
|
| 212 |
Hassnaa M. Ibrahim, Magdy Z. Elghannam, Om Ali Y. Elkhawaga, Ahmed M.A. El-Sokkary. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients. Saudi Journal of Biological Sciences 2021; 28(10): 5760 doi: 10.1016/j.sjbs.2021.06.020
|
| 213 |
De-Ling Wu, Zhen-Dong Liao, Fang-Fang Chen, Wei Zhang, Ya-Shuo Ren, Can-Can Wang, Xiao-Xiao Chen, Dai-Yin Peng, Ling-Yi Kong. Benzophenones from Anemarrhena asphodeloides Bge. Exhibit Anticancer Activity in HepG2 Cells via the NF-κB Signaling Pathway. Molecules 2019; 24(12): 2246 doi: 10.3390/molecules24122246
|
| 214 |
Qing-Qing Luo, Qiao-Nan Li, Dan Cai, Song Jiang, Shao-Song Liu, Mao-Sheng Liu, Cong Lv, Jin-Ke Wang, Kun-He Zhang, Ting Wang. The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions. Journal of Hepatocellular Carcinoma 2024; : 317 doi: 10.2147/JHC.S443273
|
| 215 |
Iuliana Nenu, Teodora Maria Toadere, Ioan Topor, Andra Țichindeleanu, Daniela Andreea Bondor, Șerban Ellias Trella, Zeno Sparchez, Gabriela Adriana Filip. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View. Biomedicines 2023; 11(10): 2623 doi: 10.3390/biomedicines11102623
|
| 216 |
Xiaoming Dai, Ruixue Huang, Sai Hu, Yao Zhou, Xiaoya Sun, Pucheng Gui, Zijian Yu, Pingkun Zhou. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00382-7
|
| 217 |
Bingbing Shang, Ruohan Wang, Haiyan Qiao, Xixi Zhao, Liang Wang, Shaoguang Sui. Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma. PeerJ 2023; 11: e15340 doi: 10.7717/peerj.15340
|
| 218 |
Yilong Zhou, Fan Liu, Chunyang Ma, Qiong Cheng. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(10) doi: 10.1002/jcla.24673
|
| 219 |
Hao Xing, Cunling Yan, Liming Cheng, Nianyue Wang, Shuyang Dai, Jianyong Yuan, Wenfeng Lu, Zhouchong Wang, Jun Han, Yijie Zheng, Tian Yang. Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma. Tumor Biology 2016; 37(12): 15447 doi: 10.1007/s13277-016-5443-x
|
| 220 |
Liyan Wang, Bin Li, Xiaotong Bo, Xiaoyuan Yi, Xuhua Xiao, Qinghua Zheng. Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway. Experimental & Molecular Medicine 2022; 54(6): 848 doi: 10.1038/s12276-022-00767-3
|
| 221 |
Chaokun Yan, Mengyuan Li, Zhihao Suo, Jun Zhang, Jianlin Wang, Ge Zhang, Wenjuan Liang, Huimin Luo. Biomarkers Identification of Hepatocellular Carcinoma Based on Multiomics
Data Integration and Graph-embedded Deep Neural Network. Current Bioinformatics 2023; 18(6): 459 doi: 10.2174/1574893618666230227122331
|
| 222 |
Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, Barbara Stefanska. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics 2018; 13(6): 605 doi: 10.1080/15592294.2018.1481706
|
| 223 |
Lei Zhang, Rong Hu, Yanyong Cheng, Xiaoyang Wu, Siwei Xi, Yu Sun, Hong Jiang. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell Proliferation 2017; 50(5) doi: 10.1111/cpr.12364
|
| 224 |
Nurbubu Moldogazieva, Innokenty Mokhosoev, Sergey Zavadskiy, Alexander Terentiev. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 2021; 9(2): 159 doi: 10.3390/biomedicines9020159
|
| 225 |
Xuan-Hai Do, Mai Thi Le, Thu Huyen Nguyen, Thanh Thien Le, Xuan-Hung Nguyen, Thanh Binh Mai, Thi My Nhung Hoang, Uyen Thi Trang Than. Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Journal of Hepatocellular Carcinoma 2023; : 783 doi: 10.2147/JHC.S409649
|
| 226 |
Wei-bin Zhang, Si-ze Hou, Yan-ling Chen, Feng Mao, Yi Dong, Jian-gang Chen, Wen-ping Wang. Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.862297
|
| 227 |
Alireza Tojjari, James Yu, Anwaar Saeed. Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma. Cancers 2024; 16(5): 1058 doi: 10.3390/cancers16051058
|
| 228 |
Pengfei Li, Jilei Pang, Shuxin Xu, Hui He, Yanyan Ma, Zhen Liu. A Glycoform‐Resolved Dual‐Modal Ratiometric Immunoassay Improves the Diagnostic Precision for Hepatocellular Carcinoma. Angewandte Chemie International Edition 2022; 61(21) doi: 10.1002/anie.202113528
|
| 229 |
Yong Liang, Zhen Liu, Dongliang Zuo, Shi Chen, Jianbin Chen, Xiaowen Yan, Pingguo Liu, Qiuquan Wang. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS. Talanta 2024; 274: 126056 doi: 10.1016/j.talanta.2024.126056
|
| 230 |
José M. Mato, Félix Elortza, Shelly C. Lu, Virginie Brun, Alberto Paradela, Fernando J. Corrales. Liver cancer-associated changes to the proteome: what deserves clinical focus?. Expert Review of Proteomics 2018; 15(9): 749 doi: 10.1080/14789450.2018.1521277
|
| 231 |
Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya, Mayank Saraswat, Anil Kumar Tomar. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genetics 2017; : 37 doi: 10.1016/j.cancergen.2017.06.002
|
| 232 |
Hanyao Sun, Wei Yang, Weizhong Zhou, Chungao Zhou, Sheng Liu, Haibin Shi, Wei Tian. Prognostic value of des‑γ‑carboxyprothrombin in patients with AFP‑negative HCC treated with TACE. Oncology Letters 2022; 25(2) doi: 10.3892/ol.2022.13655
|
| 233 |
Qi Liu, Yue Sun, Xiuwen Lan, Yue Zhu, Senqiu Qiao, Jingzeng Cai, Ziwei Zhang. Absence of Txnrd3 and its Interact Protein Anxa2 Promotes the Process of Liver Fibrosis and Development of Liver Cancer. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3928954
|
| 234 |
Jun Hyuek Yang, Hyun Soo Kim, Bon Kon Koo, Cheol Min Lee, Jong-Hyeon Jung, Young Rok Seo. Considerations of Human Health Risk Assessment in Chemical Accident: Suggestions from a Toxicogenomic Approach. Toxicology and Environmental Health Sciences 2018; 10(2): 79 doi: 10.1007/s13530-018-0350-8
|
| 235 |
Nanni Hua, Anxian Chen, Chen Yang, Hui Dong, Xianglei He, Guoqing Ru, Xiangmin Tong, Feifei Zhou, Shibing Wang. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma. Molecular Biology Reports 2022; 49(8): 7911 doi: 10.1007/s11033-022-07624-6
|
| 236 |
Zhongjian Pu, Fei Ge, Yajun Wang, Ziyu Jiang, Shilin Zhu, Shukui Qin, Qijun Dai, Hua Liu, Haiqing Hua. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Bioengineered 2021; 12(1): 2398 doi: 10.1080/21655979.2021.1932211
|
| 237 |
Thanh Hai Phan, Van Thien Chi Nguyen, Thu Thuy Thi Pham, Van-Chu Nguyen, Tan Dat Ho, Thi Mong Quynh Pham, Thanh-Huong Tran, Thanh Dat Nguyen, Nguyen Duy Khang Le, Trong-Hieu Nguyen, Minh-Long Duong, Hoai-Phuong Thi Bach, Van-Vu Kim, The-Anh Pham, Bao Toan Nguyen, Thanh Nhan Vo Nguyen, Thanh Dang Nguyen, Dung Thai Bieu Phu, Boi Hoan Huu Phan, Duy-Sinh Nguyen, Dinh-Kiet Truong, Thanh-Thuy Thi Do, Hoa Giang, Hoai-Nghia Nguyen, Minh-Duy Phan, Le Son Tran. Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma. Future Oncology 2022; 18(39): 4399 doi: 10.2217/fon-2022-1218
|
| 238 |
De‑Yong Gao, Yun Ling, Xiao‑Li Lou, Ying‑Ying Wang, Liang‑Ming Liu. GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7695
|
| 239 |
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Current Medicinal Chemistry 2020; 27(39): 6611 doi: 10.2174/0929867326666190911115722
|
| 240 |
Salsabeel S. AL-Mosht, Mohamed G. Al-Fandi, Lina M. K. Al-Ebbini. Nanoarchitectonics of composite biosensor for early detection of hepatocellular carcinoma. Applied Physics A 2022; 128(6) doi: 10.1007/s00339-022-05673-z
|
| 241 |
Yameng Zhang, Yufei Gao, Youhe Gao. Early changes in the urine proteome in a rat liver tumour model. PeerJ 2020; 8: e8462 doi: 10.7717/peerj.8462
|
| 242 |
Run-tian Ma, Xiao-bo Zhao, Xiao-yu Sun, Jia Liu, Wei Ha, Yan-ping Shi. A fluorescent molecularly imprinted device for the on-line analysis of AFP in human serum. Journal of Materials Chemistry B 2019; 7(40): 6187 doi: 10.1039/C9TB01331H
|
| 243 |
Yong Wang, Rongfen Gao, Jinpeng Li, Shaotao Tang, Shuai Li, Qiangsong Tong, Shiwang Li. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization. International Journal of Nanomedicine 2021; : 2803 doi: 10.2147/IJN.S284560
|
| 244 |
Gayathri Chalikonda, Sekani Allen, Ramakrishna Vadde, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 1 doi: 10.1016/B978-0-323-98807-0.00008-9
|
| 245 |
Zhenhua Zhang, Qingchao Li, Xin Du, Min Liu. Application of electrochemical biosensors in tumor cell detection. Thoracic Cancer 2020; 11(4): 840 doi: 10.1111/1759-7714.13353
|
| 246 |
Kalyani Dasari. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 327 doi: 10.1016/B978-0-323-98806-3.00012-X
|
| 247 |
Jian-Yao Wang, Xiang-Kun Wang, Guang-Zhi Zhu, Xin Zhou, Jun Yao, Xiao-Peng Ma, Bin Wang, Tao Peng. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08104-z
|
| 248 |
Shan Gao, Wei Hu, Xin Huang, Xingyue Huang, Wenwei Chen, Lidan Hao, Zubing Chen, Jian Wang, Hailiang Wei. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression. Cellular Signalling 2020; 72: 109621 doi: 10.1016/j.cellsig.2020.109621
|
| 249 |
Pengfei Li, Jilei Pang, Shuxin Xu, Hui He, Yanyan Ma, Zhen Liu. A Glycoform‐Resolved Dual‐Modal Ratiometric Immunoassay Improves the Diagnostic Precision for Hepatocellular Carcinoma. Angewandte Chemie 2022; 134(21) doi: 10.1002/ange.202113528
|
| 250 |
W.B. Coleman, G.J. Tsongalis. Diagnostic Molecular Pathology. 2017; : 3 doi: 10.1016/B978-0-12-800886-7.00001-7
|
| 251 |
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
|
| 252 |
Kuntay Kaplan, Yavuzalp Solak. Evaluation of YouTube Videos on Hepatocellular Carcinoma. Journal of Korean Medical Science 2023; 38(7) doi: 10.3346/jkms.2023.38.e50
|
| 253 |
Xiao-Hong Ma, Kun Chen, Shuang Wang, Si-Yun Liu, Deng-Feng Li, Yong-Tao Mi, Zhi-Yuan Wu, Chun-Feng Qu, Xin-Ming Zhao. Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model. World Journal of Gastrointestinal Oncology 2022; 14(4): 858-871 doi: 10.4251/wjgo.v14.i4.858
|
| 254 |
Seyed Mohammad Mahdi Dadfar, Sylwia Sekula-Neuner, Vanessa Trouillet, Hui-Yu Liu, Ravi Kumar, Annie K Powell, Michael Hirtz. Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP). Beilstein Journal of Nanotechnology 2019; 10: 2505 doi: 10.3762/bjnano.10.241
|
| 255 |
Weiwei Qin, He Huang, Yuting Dai, Wei Han, Youhe Gao. Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model. Respiratory Research 2022; 23(1) doi: 10.1186/s12931-022-02070-1
|
| 256 |
Andrew T. DelaCourt, Anand S. Mehta. Comprehensive Pharmacology. 2022; : 112 doi: 10.1016/B978-0-12-820472-6.00007-4
|
| 257 |
Arezoo Gowhari Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life 2021; 73(4): 659 doi: 10.1002/iub.2458
|
| 258 |
Long Zhao, Chao Xie, Danqing Liu, Tong Li, Yu Zhang, Chidan Wan. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3. Journal of Gastrointestinal Surgery 2017; 21(5): 807 doi: 10.1007/s11605-017-3386-1
|
| 259 |
Qingwen Deng, Junhong Lu, Zhichao Zeng, Yuhang Zheng, Wenbin Liu. Dynamics of Health Technology Diffusion in the Integrated Care System (DHTDICS): A Development and Validation Study in China. Risk Management and Healthcare Policy 2021; : 331 doi: 10.2147/RMHP.S293144
|
| 260 |
Han Ah Lee, Yoo Ra Lee, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo. <i>Lens culinaris</i> agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma. World Journal of Gastroenterology 2021; 27(28): 4687-4696 doi: 10.3748/wjg.v27.i28.4687
|
| 261 |
Yongjun Zhang, Mingyu Cheng, Yaxin Wang, Jian Zhang, Zhong Hua. A SERS biosensor regulated by tilt angle: an immunochip for α-fetoprotein. Journal of Materials Science 2021; 56(32): 18248 doi: 10.1007/s10853-021-06490-0
|
| 262 |
Johanna K. DiStefano. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. Non-coding RNA Research 2017; 2(3-4): 129 doi: 10.1016/j.ncrna.2017.11.001
|
| 263 |
Mohamed Eissa, Selmy Awad, Somaya Barakat, Ahmed Saleh, Salah Rozaik. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis. Medical Journal Armed Forces India 2021; 77(3): 331 doi: 10.1016/j.mjafi.2020.11.013
|
| 264 |
William B. Coleman, Gregory J. Tsongalis. Diagnostic Molecular Pathology. 2024; : 1 doi: 10.1016/B978-0-12-822824-1.00047-X
|
| 265 |
Jin Jin, Xujun Liang, Wu Bi, Ruijie Liu, Sai Zhang, Yi He, Qingming Xie, Shilei Liu, Ji-Chang Xiao, Pengfei Zhang. Identification of a Difluorinated Alkoxy Sulfonyl Chloride as a Novel Antitumor Agent for Hepatocellular Carcinoma through Activating Fumarate Hydratase Activity. Pharmaceuticals 2023; 16(12): 1705 doi: 10.3390/ph16121705
|
| 266 |
Chenfang Sun, Yi-Xuan Wang, Mingyuan Sun, Ye Zou, Congcong Zhang, Shanshan Cheng, Wenping Hu. Facile and cost-effective liver cancer diagnosis by water-gated organic field-effect transistors. Biosensors and Bioelectronics 2020; 164: 112251 doi: 10.1016/j.bios.2020.112251
|
| 267 |
Jingzhe Jin, Mingcheng Ren. The biological function of miR-128-2 in hepatocellular carcinoma and its molecular mechanism functioning. Pathology - Research and Practice 2024; 254: 155178 doi: 10.1016/j.prp.2024.155178
|
| 268 |
Abeer Mohsin, Kanwal Haneef, Amber Ilyas, Shamshad Zarina, Zehra Hashim. Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and
GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein & Peptide Letters 2021; 28(12): 1323 doi: 10.2174/0929866528666211105105953
|
| 269 |
Junqi Wang, Ke Yang, Xin Yang, Tianqiang Jin, Yu Tian, Chaoliu Dai, Feng Xu. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway. Molecular Carcinogenesis 2024; doi: 10.1002/mc.23723
|
| 270 |
Yunxun Liu, Bingbing Shen, Ting Huang, Jianguo Wang, Jianxin Jiang, Muhammad Tarek Abdel Ghafar. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients. PLOS ONE 2023; 18(7): e0288013 doi: 10.1371/journal.pone.0288013
|
| 271 |
维康 伍. Study on the Application Value of α-Fetoprotein Household Test Paper (Aifupei) in a High Risk Group of Liver Cancer. Advances in Clinical Medicine 2023; 13(01): 94 doi: 10.12677/ACM.2023.131015
|
| 272 |
Guo-Xin Zhang, Xiao-Sheng Ding, You-Li Wang. Prognostic model of hepatocellular carcinoma based on cancer grade. World Journal of Clinical Cases 2023; 11(27): 6383-6397 doi: 10.12998/wjcc.v11.i27.6383
Abstract(211) |
Core Tip(131) |
Full Article(HTML)(476)
|
Full Article with Cover (PDF)-5919K(95)
|
Full Article (Word)-3767K(12)
|
Audio-2207K(0)
|
Peer-Review Report-343K(12)
|
Answering Reviewers-140K(15)
|
Full Article (PDF)-5625K(31)
|
Full Article (XML)-92K(15)
|
Times Cited (0)
|
Total Visits (1859)
|
Open
|
| 273 |
Yichen Yang, Yuequn Ma, Meng Yuan, Yonglin Peng, Zhonghai Fang, Ju Wang. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach. Liver International 2021; 41(10): 2485 doi: 10.1111/liv.14972
|
| 274 |
Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats. Molecular Carcinogenesis 2019; 58(11): 2017 doi: 10.1002/mc.23093
|
| 275 |
Na Hu, Yuhui Wu, Maowen Tang, Tianyong Luo, Shengmei Yuan, Cai Li, Pinggui Lei. Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1005680
|
| 276 |
H. M. M. T. B. Herath, Aruna Kulatunga. Large hepatocellular carcinoma in a non-cirrhotic liver with peritoneal and omental metastasis in a healthy man: a case report. Journal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1203-9
|
| 277 |
Sufang Wang, Michael Gribskov. Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma. Molecular Genetics & Genomic Medicine 2019; 7(6) doi: 10.1002/mgg3.693
|
| 278 |
Mahdokht Kohansal-Nodehi, Magdalena Swiatek-de Lange, Konstantin Kroeniger, Vinzent Rolny, Glòria Tabarés, Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Henry Lik-Yuen Chan, Holger Busskamp. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1213898
|
| 279 |
Jing Tang, Bo Yan, Gao-Feng Li, Qiu-Yu Li, Wen-Feng Liu, Rong-Bin Liang, Qian-Min Ge, Yi Shao. Carbohydrate antigen 125, carbohydrate antigen 15–3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer. Medicine 2021; 100(43): e27693 doi: 10.1097/MD.0000000000027693
|
| 280 |
ZHONGBAO ZHANG, GUANGJU MENG, LIANG WANG, YINGYING MA, ZHONGZHENG GUAN. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma. Molecular Medicine Reports 2016; 14(1): 254 doi: 10.3892/mmr.2016.5261
|
| 281 |
Samuel Achilefu, Ramesh Raghavachari, Qi Zhang, Zhihao Han, Wancun Zhang, Zhiyu Qian, Yueqing Gu.
In vivo imaging of hepatocellular carcinoma using a glypican-3-binding peptide based probe
. Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications IX 2017; 10079: 100790T doi: 10.1117/12.2251310
|
| 282 |
Yukun Bai, Ping Wang, Yanwei Qi, Yang Li, Weidong Liu, Lei Gao, Hanliang Jiao, Yanxiao An, Yingxin Gong. Diagnostic value of HA, PC-III, IV-C, and LN in infants with congenital biliary atresia. Medicine 2022; 101(32): e29752 doi: 10.1097/MD.0000000000029752
|
| 283 |
Xiuzhi Zhang, Zhefeng Xiao, Xia Zhang, Ningning Li, Tao Sun, JinZhong Zhang, Chunyan Kang, Shasha Fan, Liping Dai, Xiaoli liu. Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03242-3
|
| 284 |
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
|
| 285 |
M. S. Chesnokov, O. M. Krivtsova, P. A. Skovorodnikova, A. S. Makarova, I. F. Kustova, M. D. Logacheva, A. A. Penin, A. V. Klepikova, D. A. Shavochkina, N. E. Kudashkin, E. A. Moroz, Y. I. Patyutko, E. A. Kotelnikova, N. L. Lazarevich. Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma. Biopolymers and Cell 2016; 32(6): 418 doi: 10.7124/bc.000939
|
| 286 |
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.72276
|
| 287 |
Sven H. Loosen, Mirco Castoldi, Markus S. Jördens, Sanchary Roy, Mihael Vucur, Jennis Kandler, Linda Hammerich, Raphael Mohr, Frank Tacke, Tom F. Ulmer, Ulf P. Neumann, Tom Luedde, Christoph Roderburg, Matias A. Avila. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLOS ONE 2021; 16(3): e0247917 doi: 10.1371/journal.pone.0247917
|
| 288 |
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors. Journal of Cancer Research and Clinical Oncology 2021; 147(1): 49 doi: 10.1007/s00432-020-03378-5
|
| 289 |
Archu Singh, Sadat Shafi, Tanya Upadhyay, Abul Kalam Najmi, Kanchan Kohli, Faheem Hyder Pottoo. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Current Topics in Medicinal Chemistry 2020; 20(20): 1839 doi: 10.2174/1568026620666200624161801
|
| 290 |
Soroosh Sabeti, Redouane Ternifi, Nicholas B. Larson, Michael C. Olson, Thomas D. Atwell, Mostafa Fatemi, Azra Alizad. Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121664
|
| 291 |
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances. 2023; : 31 doi: 10.1016/B978-0-323-98368-6.00009-4
|
| 292 |
Fatah Ben Moussa. Molecularly imprinted polymers meet electrochemical cancer chemosensors: A critical review from a clinical and economic perspective. Microchemical Journal 2023; 191: 108838 doi: 10.1016/j.microc.2023.108838
|
| 293 |
Hebatalla Said Ali, Mariam Sameh Boshra, Mahmoud Shawky El Meteini, Ayman El-Sayed Shafei, Marwa Matboli. lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR/Cas9 editing in hepatocellular carcinoma. Genomics 2020; 112(5): 3306 doi: 10.1016/j.ygeno.2020.06.020
|
| 294 |
Hong Kiat Lim, Gary P. Jeffrey, Grant A. Ramm, Carolina Soekmadji. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.587628
|
| 295 |
Danli Yang, Mingjie Yao, Ying Yan, Yanna Liu, Xiajie Wen, Xiangmei Chen, Fengmin Lu. Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease. Biomolecules 2021; 11(2): 205 doi: 10.3390/biom11020205
|
| 296 |
Xiangyan Xiao, Qiyuan Huang, Xiaocong Lin, Kashif Rafiq Zahid, Xueran Huang, Tiancai Liu, Tao Zeng. Current methods for the detection of glypican-3. Analytical Methods 2024; 16(2): 152 doi: 10.1039/D3AY01523H
|
| 297 |
Wenqing Cao, Meenal Sharma, Rami Imam, Jiangzhou Yu. Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2019; 152(5): 647 doi: 10.1093/ajcp/aqz086
|
| 298 |
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma 2021; : 1579 doi: 10.2147/JHC.S327339
|
| 299 |
Dan Wang, Baolan Wan, Xiaojing Zhang, Pingping Sun, Shu Lu, Chenxu Liu, Li Zhu. Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02260-7
|
| 300 |
Tommaso A. Dragani, Valerie Matarese, Francesca Colombo. Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics. BioEssays 2020; 42(4) doi: 10.1002/bies.201900122
|
| 301 |
Wenbiao Chen, Donge Tang, Minglin Ou, Yong Dai. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes. DNA and Cell Biology 2020; 39(4): 499 doi: 10.1089/dna.2019.5099
|
| 302 |
Giuseppa Augello, Alessandra Cusimano, Melchiorre Cervello, Antonella Cusimano. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview. Cancers 2024; 16(7): 1415 doi: 10.3390/cancers16071415
|
| 303 |
Xiao-Hong Ma, Shuang Wang, Si-Yun Liu, Kun Chen, Zhi-Yuan Wu, Deng-Feng Li, Yong-Tao Mi, Long-Bin Hu, Zhong-Wei Chen, Xin-Ming Zhao. Development and <i>in vitro</i> study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(24): 3030-3043 doi: 10.3748/wjg.v25.i24.3030
|
| 304 |
Fanghua Chen, Junming Wang, Yingcheng Wu, Qiang Gao, Shu Zhang. Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.822449
|
| 305 |
Dongxia Li, Lizhen Zeng, Yuanli Wang, Hong-Wen Tang, Wen Xing Lee, Zhencheng Chen, Longhui Zhang, Yingchang Zou, Duan Xie, Fangrong Hu. Terahertz metamaterial biosensor for diagnosis of hepatocellular carcinoma at early stage. Applied Optics 2022; 61(16): 4817 doi: 10.1364/AO.459489
|
| 306 |
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
|
| 307 |
Biyuan Luo, Fang Ma, Hao Liu, Jixiong Hu, Le Rao, Chun Liu, Yongfang Jiang, Shuyu Kuangzeng, Xuan Lin, Chenyang Wang, Yiyu Lei, Zhongzhou Si, Guangshun Chen, Ning Zhou, Chengbai Liang, Fangqing Jiang, Fenge Liu, Weidong Dai, Wei Liu, Yawen Gao, Zhihong Li, Xi Li, Guangyu Zhou, Bingsi Li, Zhihong Zhang, Weiqi Nian, Lihua Luo, Xianling Liu. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Medicine 2022; 20(1) doi: 10.1186/s12916-021-02201-3
|
| 308 |
Ying Kong, Hao Chen, Mengyu Chen, Yongshuai Li, Jiarong Li, Qi Liu, Huan Xiong, Tangxi Guo, Yan Xie, Yufeng Yuan, Xiao-Lian Zhang. Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.855952
|
| 309 |
Qingmei Deng, Xinhui Zhang, Xiaofeng Wan, Xin Zheng, Hongzhi Wang, Jingyu Zhao, Hong-Qiang Wang, Wulin Yang. The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma. Heliyon 2024; 10(5): e26774 doi: 10.1016/j.heliyon.2024.e26774
|
| 310 |
WEN-ZHOU DING, QING-FENG NI, YE-TING LU, LIANG-LIANG KONG, JIAN-JUN YU, LONG-WEI TAN, LIAN-BAO KONG. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters 2016; 11(2): 1081 doi: 10.3892/ol.2015.3981
|
| 311 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 312 |
Hongwei Wu, Lijing Fan, Haiping Liu, Baozhang Guan, Bo Hu, Fanna Liu, Berthold Hocher, Lianghong Yin. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4030915
|
| 313 |
Emma Reungoat, Boyan Grigorov, Fabien Zoulim, Eve-Isabelle Pécheur. Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers 2021; 13(9): 2270 doi: 10.3390/cancers13092270
|
| 314 |
Jian Li, Tiezheng Wang, Boxun Jin, Wenlei Li, Zhenshun Wang, Haitao Zhang, Yunjun Song, Ning Li. Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis. The International Journal of Biological Markers 2018; 33(4): 353 doi: 10.1177/1724600818784409
|
| 315 |
Yi Jiang, Lu Guo, Lei Han, Han Li, Changlun Li, Lianbin Wen, Yanqiong Song, Zhaoyang Wang, Pan Wang, Qulian Guo, Wenxi Zhao, Mengxiang Liu, Jiali Chen, Zhenying Wu, Yushan Yan, Ke Xu, Tao Gu, Xue Wu, Kun He, Ke Su, Yunwei Han. Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study. Journal of Cancer Research and Clinical Oncology 2023; 149(15): 14271 doi: 10.1007/s00432-023-05089-z
|
| 316 |
Bin Sun, Weidan Ji, Chunying Liu, Xuejing Lin, Lei Chen, Haihua Qian, Changqing Su. miR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2. Liver International 2022; 42(7): 1658 doi: 10.1111/liv.15284
|
| 317 |
Mona A. Omar, Mohamed M. Omran, Khaled Farid, Ashraf A. Tabll, Yasser E. Shahein, Tarek M. Emran, Ana Petrovic, Nikola R. Lucic, Robert Smolic, Tanja Kovac, Martina Smolic. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines 2023; 11(7): 1852 doi: 10.3390/biomedicines11071852
|
| 318 |
Yalei Zhao, Chen Xue, Zhongyang Xie, Xiaoxi Ouyang, Lanjuan Li. Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma. Cell Proliferation 2020; 53(10) doi: 10.1111/cpr.12908
|
| 319 |
Alyson P Black, Anand S Mehta. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Current Opinion in Pharmacology 2018; 41: 74 doi: 10.1016/j.coph.2018.04.002
|
| 320 |
Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Yee Lau, Tian Yang. Clinical utility of serum biomarkers for hepatocellular carcinoma. Biomarkers in Medicine 2021; 15(3): 151 doi: 10.2217/bmm-2020-0474
|
| 321 |
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Annals of Hepatology 2020; 19(2): 179 doi: 10.1016/j.aohep.2019.09.002
|
| 322 |
Jing Tang, Yunxia Wang, Yongchao Luo, Jianbo Fu, Yang Zhang, Yi Li, Ziyu Xiao, Yan Lou, Yunqing Qiu, Feng Zhu. Computational advances of tumor marker selection and sample classification in cancer proteomics. Computational and Structural Biotechnology Journal 2020; 18: 2012 doi: 10.1016/j.csbj.2020.07.009
|
| 323 |
Antonio Lacalamita, Grazia Serino, Ester Pantaleo, Alfonso Monaco, Nicola Amoroso, Loredana Bellantuono, Emanuele Piccinno, Viviana Scalavino, Francesco Dituri, Sabina Tangaro, Roberto Bellotti, Gianluigi Giannelli. Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(20): 15286 doi: 10.3390/ijms242015286
|
| 324 |
Manyu Li, Jing Sun, Yan Wang, Jun Ma, Xiaotian Hao, Yan Liu, Cheng Zhou, Haiwei Zhou. Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment. The American Journal of the Medical Sciences 2024; 367(3): 181 doi: 10.1016/j.amjms.2023.11.016
|
| 325 |
Lijie Xia, Qiao Teng, Qi Chen, Fuchun Zhang. <p>Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma</p>. International Journal of Nanomedicine 2020; : 2197 doi: 10.2147/IJN.S235058
|
| 326 |
Yi Shi, Jingrui Men, Hongliang Sun, Jianjun Tan. The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 2022; 18(10): 1073 doi: 10.2174/1573406418666220404084532
|